---
title: "Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300789929.md"
description: "Nike shares plunged 9.5% in pre-market trading after reporting mixed Q1 results, with revenue of $11.21 billion missing estimates despite beating earnings per share forecasts. This decline contributed to a broader drop among major stocks including Roze AI, Mangoceuticals, and others in Friday's pre-session."
datetime: "2026-10-02T12:02:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300789929.md)
  - [en](https://longbridge.com/en/news/300789929.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300789929.md)
generator: "portal-rs"
---

# Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.

Shares of **Nike Inc** (NYSE:NKE) fell sharply in pre-market trading after the company reported mixed first-quarter financial results.

Nike reported first-quarter revenue of $11.21 billion, missing analyst estimates of $11.33 billion, according to Benzinga Pro. The company posted adjusted earnings of 48 cents per share for the quarter, beating estimates of 44 cents per share.

Nike shares dipped 9.5% to $31.82 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

-   **Roze AI** (NASDAQ:RZAI) fell 12.3% to $23.07 in pre-market trading after dipping 29% on Thursday.
-   **Mangoceuticals, Inc**. (NASDAQ:MGRX) declined 10.3% to $0.4310 in pre-market trading as the company announced its former subsidiary secured a $2.5 million strategic investment.
-   **Quantum-Si Inc** (NASDAQ:QSI) fell 6.3% to $1.34 in pre-market trading after gaining 34% on Thursday.
-   **Target Hospitality Corp**. (NASDAQ:TH) declined 6% to $19.25 in pre-market trading after gaining around 4% on Thursday.
-   **Fair Isaac Corporation** (NYSE:FICO) dipped 6% to $622.50 in pre-market trading after jumping around 12% on Thursday.
-   **Cheniere Energy, Inc**. (NYSE:LNG) shares fell 5.1% to $258.50 in the pre-market trading.
-   **Edison International** (NYSE:EIX) declined 4.6% to $51.35 in pre-market trading.
-   **Ascentage Pharma Group** (NASDAQ:AAPG) fell 4.3% to $15.22 in pre-market trading following a 4% decline on Thursday.
-   **Stewards Inc.** (NASDAQ:SWRD) declined 4% to $2.1902 in pre-market trading after falling around 6% on Thursday.
-   **Equifax Inc.** (NYSE:EFX) fell 3.4% to $135.00 in pre-market trading.

*Photo via Shutterstock*

### Related Stocks

- [AAPG.US](https://longbridge.com/en/quote/AAPG.US.md)
- [EFX.US](https://longbridge.com/en/quote/EFX.US.md)
- [EIX.US](https://longbridge.com/en/quote/EIX.US.md)
- [FICO.US](https://longbridge.com/en/quote/FICO.US.md)
- [LNG.US](https://longbridge.com/en/quote/LNG.US.md)
- [MGRX.US](https://longbridge.com/en/quote/MGRX.US.md)
- [NKE.US](https://longbridge.com/en/quote/NKE.US.md)
- [QSI.US](https://longbridge.com/en/quote/QSI.US.md)
- [RZAI.US](https://longbridge.com/en/quote/RZAI.US.md)
- [SWRD.US](https://longbridge.com/en/quote/SWRD.US.md)
- [TH.US](https://longbridge.com/en/quote/TH.US.md)
- [IGBH.US](https://longbridge.com/en/quote/IGBH.US.md)
- [MSTX.US](https://longbridge.com/en/quote/MSTX.US.md)

## Related News & Research

- [Buy Nike Stock (NKE) Ahead of Earnings, Says Jefferies](https://longbridge.com/en/news/300340314.md)
- [Nike Just Reported Earnings. Here's What Investors Need to Know.](https://longbridge.com/en/news/300813690.md)
- [Equifax (EFX) Could Be 35% Undervalued Following New Fraud Tool Launches](https://longbridge.com/en/news/300866762.md)
- [NIKE (NYSE:NKE) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS](https://longbridge.com/en/news/300726242.md)
- [ANALYSIS-Nike's struggles test investor confidence in CEO Hill's turnaround effort](https://longbridge.com/en/news/300786999.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**